Section Arrow
MDXH.NASDAQ
- MDxHealth SA
Quotes are at least 15-min delayed:2024/09/28 16:02 EDT
Last
 2.07
+0.07 (+3.50%)
Day High 
2.14 
Prev. Close
1-M High
2.9799 
Volume 
284.75K 
Bid
2.01
Ask
2.34
Day Low
2.03 
Open
2.08 
1-M Low
1.99 
Market Cap 
54.58M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 2.53 
20-SMA 2.68 
50-SMA 2.76 
52-W High 4.64 
52-W Low 0.35 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.48/-0.13
Enterprise Value
93.72M
Balance Sheet
Book Value Per Share
-0.32
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
70.19M
Operating Revenue Per Share
2.03
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ME23andMe Holding Co0.2941-0.0241-7.57%-- 
OPKOPKO Health1.52+0.03+2.01%-- 
MYNZMainz Biomed NV0.247+0.0331+15.47%-- 
AAgilent Technologies148.06+1.32+0.90%30.51PE
QGENQiagen NV45.24+0.22+0.49%130.2PE
Quotes are at least 15-min delayed:2024/09/28 16:02 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensingof the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.